Not currently recruiting at University of California Health
Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study)
Summary
- Eligibility
- for females ages 12 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
- Principal Investigator
- by Richard Haas, MD (ucsd)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Richard Haas, MD (ucsd)
Recall Hcomp, Neurosciences, Vc-health Sciences-schools. Authored (or co-authored) 5 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Taysha Gene Therapies, Inc.
- ID
- NCT05606614
- Phase
- Phase 1/2 Rett Syndrome Research Study
- Study Type
- Interventional
- Participants
- Expecting 18 study participants
- Last Updated